161 Fort Washington AvenueNew York, NY 10032
Overview of Dr. Faiena
Dr. Izak Faiena is an urologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian Hudson Valley Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and James J. Peters Veterans Affairs Medical Center. He received his medical degree from Albert Einstein College of Medicine and has been in practice 16 years. He is one of 16 doctors at James J. Peters Veterans Affairs Medical Center and one of 63 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Urology. He has more than 90 publications and over 500 citings.
Education & Training
David Geffen School of Medicine at UCLAMSCR, Urologic Oncology, 2016 - 2019
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Urology, 2012 - 2016
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Surgery, 2010 - 2012
Albert Einstein College of MedicineClass of 2010
Yeshiva UniversityB.A., Biology, Summa Cum Laude, 2006
Certifications & Licensure
NJ State Medical License Current
NY State Medical License 2019 - 2026
CA State Medical License 2015 - 2019
American Board of Urology Urology
Awards, Honors, & Recognition
- Resident Research Award, Division of Urology 2015
- Resident Research Award for Best Oral Presentation RWJMS, 2014
- Excellence in Leadership Award Albert Einstein College of Medicine, 2010
Publications & Presentations
PubMed
- The Critical Difference Between Understanding and Consent: Lessons From Germline and Somatic Testing for Metastatic Prostate Cancer.Shane Kronstedt, Kevin Rice, Izak Faiena, Brian F Chapin
JCO Oncology Practice. 2026-03-01 - 1 citationsAbiraterone vs Enzalutamide Among US Veterans With Metastatic Hormone-Sensitive Prostate Cancer.Harshraj Leuva, Mengxi Zhou, Benjamin A Teply, Yeun-Hee Anna Park, Carol Luhrs
JAMA Network Open. 2025-11-03 - 2 citationsAssessing olaparib efficacy in U.S. Veterans with metastatic prostate cancer utilizing a time-indifferent g-rate method ideal for real-world analyses.Harshraj Leuva, Mengxi Zhou, Nader Jamaleddine, Mina Meseha, Izak Faiena
Ebiomedicine. 2024-09-01
Journal Articles
- Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance ImagingSteven S Raman, Sohrab A Mirak, Izak Faiena, Aydin Pooli, Amirali Salmasi, Ely R Felker, European Urology
- Radical Prostatectomy Then and Now: Surgical Overtreatment of Prostate Cancer Is Declining from 2009 to 2016 at a Tertiary Referral CenterAmirali Salmasi, Izak Faiena, Karim Chamie, Urologic Oncology
- Impact of Uncontrolled Diabetes on Outcomes after Cystectomy in Patients with Bladder Cancer: A Population-based StudyFaiena I, Dombrovskiy VY, Sultan RC, Salmasi AH, Singer EA, Weiss RE, Clinical Genitourinary Cancer, 1/1/2016
Books/Book Chapters
Abstracts/Posters
- From Moon Rocks to Kidney Stones: A Look at the Evolution of the CyberWandRutveej Patel, Izak Faiena, Sammy E. Elsamra, AUA National Meeting, 1/1/2016
- Outcomes of Men with Locally Advanced or Regionally Advanced Prostate Cancer Following Conservative Management (CM)Parth Modi, Izak Faiena, Neal Patel, Shunhua Shen, Eric A. Singer, Dirk Moore, Robert DiPaola, Grace Lu-Yao, Isaac Y. Kim, Thomas L. Jang, AUA National Meeting, 1/1/2016
- Adrenalectomy for Benign and Malignant Disease: Utilization and Outcomes by Surgeon Specialty and Surgical ApproachIzak Faiena, Alexandra Tabakin, Jeffrey Leow, Neal Patel, Parth K. Modi, Amirali H. Salmasi, Benjamin I. Chung, Steven L. Chang, Eric A. Singer, AUA National Meeting, 1/1/2016
Authored Content
- Re: Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma After NephrectomyFebruary 2018
- Re: Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma After NephrectomyFebruary 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










